Biocon’s biosimilar biz tops $4 bn in valuation
Abu Dhabi-based sovereign wealth fund ADQ has picked up 1.80% stake in Biocon Biologics for $75 million; The company already raised $255 million from global marquee investors last year.
kiran mazumdar shaw individual 2
January 2021
April 2020
February 2020
January 2020
September 2019
August 2019
July 2019
November 2018
‘Restart economy sooner than later’
India is likely to recover faster than the rest of the world from the economic turmoil caused by Covid-19, with new opportunities presenting themselves, says Biocon chairperson.
Shaw named EY Entrepreneur of the Year
The award recognises entrepreneurs who, with their disruptive ideas and passion for growth, are creating successful global enterprises.
Budget: Where is the short-term boost, asks India Inc.
The Budget rightly focusses on rural and agrarian growth, infrastructure creation, and a digital future, but misses out on a much-needed consumption boost.
True North invests ₹536 crore in Biocon arm
The private equity firm’s investment values Biocon Biologics at about $3 billion on a pre-money equity basis.
Most Powerful Women 2019: Blazing a trail
Editor’s letter from September 15 - December 14, 2019 issue of the magazine
The long road ahead
The government aims to turn India into a $5-trillion economy in the next five years, but it has to cross several hurdles along the way.
V.G. Siddhartha: Death of an eternal optimist
The Café Coffee Day founder’s death has shocked business leaders, who considered him to be a resilient entrepreneur and an optimist.
Good blueprint, but gaps remain: India Inc.
Focus on infra, housing, financial services, labour reforms welcome; but concerns remain on corporate tax, ability to meet disinvestment target.
Kiran Mazumdar-Shaw: Grit is her secret formula
Overcoming years of criticism and gender bias, Mazumdar-Shaw has proven naysayers wrong by positioning Biocon as an Indian pioneer in the lucrative biologic drugs market.
